Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The firm has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).
Follow-Up Questions
¿Cuál es el ratio P/E de Acusphere Inc (ACUS)?
El ratio P/E de Acusphere Inc es 0
¿Quién es el CEO de Acusphere Inc?
Mr. Mark Leuchtenberger es el President de Acusphere Inc, se unió a la empresa desde 2013.
¿Qué tal es el rendimiento del precio de la acción ACUS?
El precio actual de ACUS es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Acusphere Inc?
Acusphere Inc pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Acusphere Inc?
La capitalización bursátil actual de Acusphere Inc es $0
